patient information dannie newman paab reviewer

9
Patient Information Dannie Newman dannien&@paab.ca PAAB Reviewer

Upload: caitlin-walker

Post on 19-Jan-2018

212 views

Category:

Documents


0 download

DESCRIPTION

Arbace HCT is a tablet containing both arbsartan and the diuretic hydrochlorothiazide. Can we create a patient counselling tool which is branded for both Arbace and Arbace HCT? No

TRANSCRIPT

Page 1: Patient Information Dannie Newman PAAB Reviewer

Patient Information

Dannie Newmandannien&@paab.caPAAB Reviewer

Page 2: Patient Information Dannie Newman PAAB Reviewer

Thought Process Sequence

Is the piece only about the specific product which was prescribed?

2

Page 3: Patient Information Dannie Newman PAAB Reviewer

Arbace HCT is a tablet containing both arbsartanand the diuretic hydrochlorothiazide. Can we create a patient counselling tool which is brandedfor both Arbace and Arbace HCT?

No

Page 4: Patient Information Dannie Newman PAAB Reviewer

Thought Process Sequence

Is the piece only about the specific product which was prescribed?

Is the drug content consistent with Part III of the Product

Monograph?AND

Is the disease content on label and supported by standard setting organizations or authoritative sources?

4

Page 5: Patient Information Dannie Newman PAAB Reviewer

Standard Setting Organizations

What they are:• Group generally considered to be a credible source for

patient information • Package complex medical information in a manner

which is easy for patients to understand

What they aren't: • A person• A commercial website • Controlled by pharma

5

Page 6: Patient Information Dannie Newman PAAB Reviewer

Standard Setting Organizations

Examples:• Patient groups (e.g., the Asthma Society of Canada)

• Medical institutions (e.g., a hospital) • Health care professional organizations

(e.g., Canadian Nurses Association)

• Consensus groups (e.g., Canadian Diabetes Association)

6

Page 7: Patient Information Dannie Newman PAAB Reviewer

Thought Process Sequence

Is the piece only about the specific product which was prescribed?

Is the drug content consistent with Part III of the Product

Monograph?AND

Is the disease content on label and supported by standard setting organizations or authoritative sources?

Is the piece non-promotional?

7

Page 8: Patient Information Dannie Newman PAAB Reviewer

Thought Process Sequence

Is the piece only about the specific product which was prescribed?

Is the drug content consistent with Part III of the Product

Monograph?AND

Is the disease content on label and supported by standard setting organizations or authoritative sources?

Is the piece non-promotional?

Is risk information from Part III of the Product Monograph

required?

8

Page 9: Patient Information Dannie Newman PAAB Reviewer

Questions